Evolving strategies: Enhancements in managing eosinophilic esophagitis in pediatric patients.

Autor: Elghoudi A; Department of Pediatric, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Zourob D; Division of Pediatric Gastroenterology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Al Atrash E; Division of Pediatric Gastroenterology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Alshamsi F; Pediatric Residency Program, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Alkatheeri M; Division of Pediatric Gastroenterology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Narchi H; College of Medicine and Health Sciences, United Arab Emirates University, Alain, Abu Dhabi, United Arab Emirates., Bitar R; Division of Pediatric Gastroenterology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. rahmad@seha.ae.
Jazyk: angličtina
Zdroj: World journal of clinical pediatrics [World J Clin Pediatr] 2024 Mar 09; Vol. 13 (1), pp. 89580. Date of Electronic Publication: 2024 Mar 09 (Print Publication: 2024).
DOI: 10.5409/wjcp.v13.i1.89580
Abstrakt: Eosinophilic esophagitis is a newly recognized disease first described about 50 years ago. The definition, diagnosis, and management have evolved with new published consensus guidelines and newly approved treatment available to pediatricians, enabling a better understanding of this disease and more targeted treatment for patients. We describe the definition, presentation, and diagnosis of eosinophilic esophagitis including management, challenges, and future directions in children. The definition, diagnosis, and management of eosinophilic esophagitis have evolved over the last 50 years. Consensus guidelines and newly approved biologic treatment have enabled pediatricians to better understand this disease and allow for more targeted treatment for patients. We describe the definition, presentation, diagnosis, management, and treatment in addition to the challenges and future directions of eosinophilic esophagitis management in children.
Competing Interests: Conflict-of-interest statement: The authors have no conflicts of interest to declare.
(©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.)
Databáze: MEDLINE